Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

Post-operative radiotherapy in NSCLC shows no statistically difference in 3-year disease-free survival

Post-operative radiotherapy in NSCLC shows no statistically difference in 3-year disease-free survival

KRASG12C inhibitor sotorasib shows durable clinical benefits for solid cancers

KRASG12C inhibitor sotorasib shows durable clinical benefits for solid cancers

Study finds wide variation in levels and anti-tumor effectiveness of a common cancer drug

Study finds wide variation in levels and anti-tumor effectiveness of a common cancer drug

UofL receives $11.5 million to accelerate the development of new immunotherapies

UofL receives $11.5 million to accelerate the development of new immunotherapies

Suppressing tumor's growth and spread from the inside

Suppressing tumor's growth and spread from the inside

New diagnostic tool can predict cancer patients' response to immunotherapy

New diagnostic tool can predict cancer patients' response to immunotherapy

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Heat Biologics SARS-CoV-2 vaccine generates potent T cell response in pre-clinical trial

Heat Biologics SARS-CoV-2 vaccine generates potent T cell response in pre-clinical trial

Highly expressed protein in lung cancer cells drives resistance to targeted therapies

Highly expressed protein in lung cancer cells drives resistance to targeted therapies

FDA approves first companion diagnostic that uses liquid biopsy and NGS technology

FDA approves first companion diagnostic that uses liquid biopsy and NGS technology

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Lung cancer study highlights important factors for treating genomically complicated cancers

Lung cancer study highlights important factors for treating genomically complicated cancers

Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment

Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment

Researchers to receive Real-World Data Impact Award to advance patient-centric research

Researchers to receive Real-World Data Impact Award to advance patient-centric research

Artificial neural network can provide information about lung cancer severity

Artificial neural network can provide information about lung cancer severity

ACCC releases preliminary results from survey on stage III and IV lung cancer care

ACCC releases preliminary results from survey on stage III and IV lung cancer care

Study highlights role of EGFR mutations in predicting recurrence in lung cancer

Study highlights role of EGFR mutations in predicting recurrence in lung cancer